Brief: Cellect Biotechnology Reports Fourth Quarter And Full Year 2019 Results
April 3 (Reuters) - Cellect Biotechnology Ltd APOP.O :
* CELLECT BIOTECHNOLOGY REPORTS FOURTH QUARTER AND FULL YEAR
2019
RESULTS
* CELLECT BIOTECHNOLOGY LTD - TOTAL COMPREHENSIVE LOSS WAS
$0.008
PER SHARE FOR Q4
Source text for Eikon: ID:nPn3JrtyGa
Further company coverage: APOP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM